MIR6763

Across TCGA pan-cancer cohorts, MIR6763 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR6763 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR6763 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR6763 expression acts as an unfavorable survival marker, although some lineages such as STAD and UCS show a favorable association.

STAD, LUSC, and UCS are the cancer types where MIR6763 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Quartile	III,IV	0.849	0.358	.005	36	view →
LUSC	OS	Tertile	IV	0.057	0.786	.008	36	view →
UCS	DFS	Tertile	IV	0.978	0.478	.018	34	view →
KIRC	DFS	Quartile	III,IV	0.308	0.514	.006	32	view →
THYM	DFS	Median	III,IV	1.000	0.402	.004	28	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	24	view →
BLCA	OS	Quartile	III,IV	0.241	0.537	.001	21	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
ACC	OS	Tertile	III,IV	0.306	0.781	.003	17	view →
TGCT	DFS	Median	All	0.518	0.769	.016	12	view →
UVM	OS	Quartile	III,IV	0.330	0.760	.013	8	view →
CESC	DFS	Tertile	II,III,IV	0.666	0.816	.015	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR6763–STAD (OS)

Open the STAD breakdown →